Mesoblast Limited (MESO)
NASDAQ·Healthcare·Biotechnology
$14.27
+1.19%
Mkt Cap $1.99B
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$39.00
Range $39.00 – $39.00
Implied Upside
+173.3%
Consensus $39.00 vs current $14.27
NASDAQ·Healthcare·Biotechnology
$14.27
+1.19%
Mkt Cap $1.99B
No recent rating data.
Price Target (3 analysts)
$39.00
Range $39.00 – $39.00
+173.3%
Consensus $39.00 vs current $14.27